Results 221 to 230 of about 23,635 (276)

Effectiveness and safety of methylprednisolone combination with abrocitinib compared to methylprednisolone combination with azathioprine in bullous pemphigoid: a retrospective study. [PDF]

Sci Rep
Chen Y, Zhuang Z, Mao J, Bao S, Zhang Y, Wu Z, Chen W, Tong Z, Gong T, Ji C.   +9 more
europepmc   +1 more source

Bullous pemphigoid: epidemiological, clinical, and therapeutic analysis of 189 patients in a tertiary center in Brazil. [PDF]

An Bras Dermatol
Honorato CMA, Santi CG, Maruta CW, Aoki V, Miyamoto D.   +4 more
europepmc   +1 more source

Gliptin-Induced Bullous Pemphigoid: A Case Series

International Journal of Medical Science and Innovative Research (IJMSIR)
openalex   +1 more source

A case series of vildagliptin-associated bullous pemphigoid - Rare side effect.

Indian J Pharmacol
Shahi MK, Ashwin JV, Singh A, Gupta S, Surya K.   +4 more
europepmc   +1 more source

Effective response to high-frequency and prolonged dupilumab therapy in severe refractory bullous pemphigoid: A case study. [PDF]

Hum Vaccin Immunother
Jiang X, Chen L, Zhu Y, Zhan S, Jin N, Cheng H.   +5 more
europepmc   +1 more source

Identification of distinct epitopes in dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid. [PDF]

Sci Adv
Mai S, Mai Y, Ujiie I, Izumi K, Natsuga K, Nishie W, Ujiie H.   +6 more
europepmc   +1 more source

Transforming growth factor alpha promotes bullous pemphigoid pathogenesis by disrupting cell adhesion and inducing inflammation. [PDF]

Cell Mol Life Sci
Wang S, Peng X, Ran Y, Feng R, Xia Y, Liu Y.   +5 more
europepmc   +1 more source

A Rare Case of Bullous Pemphigoid Triggered by Overlapping Immune Dysregulation From HIV and Hodgkin Lymphoma: A Case Report. [PDF]

Cureus
Palacio I, Arraut K, Portalatin K, Estil-Las AA, Grace M.   +4 more
europepmc   +1 more source

Correction: Evaluation of a novel chemiluminescent immunoassay for autoantibody detection in pemphigus and bullous pemphigoid. [PDF]

Front Immunol
Zhang N, Wang M, Hou L, Zhang Y, Zhao Y, Du L, Li X, Liu X, Zhou H, Hao J, Tian J, Yu Q, Li L, Cheng F, Zhou HZ.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Bullous pemphigoid

Autoimmunity Reviews, 2017
Bullous pemphigoid (BP) is the most common autoimmune bullous disorder which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. Collagen XVII and dystonin-e have been identified as target antigens. BP affects mostly the elderly. The incidence of the disease is increasing gradually and is associated with
Işın S Bağcı, Orsolya N Horváth
exaly   +4 more sources